Physician
Florida Clinical Practice Association INC
Florida Clinical Practice Association INC was paid $79.31M by Medicaid between Jan 2018 and Oct 2024, across 586 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoFLORIDA CLINICAL PRACTICE ASSOCIATION INC
GAINESVILLE, FL 32610
GAINESVILLE, FL 32610
33aNPI1063463768assigned 05/15/2006
33bProvider typeFamily Medicine Physician
28Total paid$79.31M
24GClaims5,610,229
24DCodes billed586
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Family Medicine Physician providers in Florida
Rank by total paid#1 of 996
Median peer was paid$13K
This provider vs. median5,977×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 183,598 | $587K | |
| 2019 | 801,853 | $12.28M | |
| 2020 | 879,951 | $12.18M | |
| 2021 | 1,035,412 | $15.30M | |
| 2022 | 1,064,358 | $16.78M | |
| 2023 | 1,134,957 | $17.32M | |
| 2024incomplete | 510,100 | $4.87M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 270,011 | 242,884 | $11.87M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.9% | 194,244 | 179,138 | $6.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.7% | 89,062 | 81,995 | $6.12M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.9% | 54,438 | 48,068 | $4.65M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.3% | 94,793 | 33,055 | $3.45M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.5% | 17,729 | 16,792 | $1.97M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.4% | 25,786 | 24,375 | $1.87M |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | 2.2% | 5,155 | 1,249 | $1.73M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 21,960 | 18,956 | $1.32M |
| H1000 | Prenatal care, at-risk assessment | 1.6% | 26,511 | 20,957 | $1.29M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 16,723 | 15,010 | $1.24M |
| 99223 | Prolong inpt eval add15 m | 1.5% | 13,584 | 11,638 | $1.17M |
574 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.4% | 12,775 | $1.15M |
| 99232 | Hospital visit by a doctor, follow-up day | 1.4% | 41,612 | $1.13M |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 1.4% | 3,770 | $1.11M |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | 1.3% | 10,213 | $1.03M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 27,085 | $1.03M |
| 99480 | Subsequent intensive care, per day, low birth weight infant | 1.3% | 10,612 | $1.01M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 13,274 | $982K |
| 82805 | 1.2% | 70,464 | $963K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 32,466 | $949K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.1% | 12,425 | $898K |
| 59410 | 1.0% | 716 | $811K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 6,680 | $763K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 7,538 | $692K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 351,416 | $627K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 9,661 | $625K |
| T1017 | Case management, billed per 15 minutes | <1% | 25,995 | $554K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 10,258 | $518K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 37,772 | $488K |
| 99283 | Emergency room visit (moderate) | <1% | 8,646 | $476K |
| 90837 | Psychotherapy session, about an hour | <1% | 4,803 | $456K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 31,376 | $443K |
| 71045 | Radiologic examination, chest; single view | <1% | 132,883 | $441K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,049 | $432K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 3,229 | $425K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 105,219 | $412K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12,383 | $405K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15,487 | $396K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 8,160 | $377K |
| 54161 | <1% | 1,976 | $373K | |
| 97803 | <1% | 8,989 | $363K | |
| 80053 | Comprehensive metabolic panel | <1% | 221,380 | $338K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 5,350 | $330K |
| 82947 | <1% | 171,033 | $323K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 9,622 | $315K |
| 83735 | <1% | 273,023 | $301K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 4,525 | $286K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 5,685 | $286K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 4,973 | $286K |
| 88307 | <1% | 4,456 | $278K | |
| 93304 | <1% | 7,229 | $272K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 202,603 | $247K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,771 | $245K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 4,573 | $242K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,862 | $239K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 50,622 | $236K |
| 82330 | <1% | 56,264 | $213K | |
| 99205 | Prolong outpt/office vis | <1% | 1,497 | $200K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16,157 | $199K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 541 | $197K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,261 | $195K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 706 | $188K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,184 | $183K |
| 86141 | <1% | 76,752 | $182K | |
| 59025 | Fetal non-stress test | <1% | 8,870 | $172K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 7,291 | $163K |
| 85027 | <1% | 112,875 | $161K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,308 | $158K |
| 82803 | <1% | 27,045 | $158K | |
| 95782 | <1% | 1,354 | $146K | |
| 86850 | <1% | 59,110 | $145K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,748 | $142K |
| 90686 | <1% | 7,729 | $141K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,306 | $140K |
| 99243 | <1% | 1,742 | $137K | |
| 83605 | <1% | 82,126 | $133K | |
| 74018 | <1% | 33,441 | $132K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 4,695 | $129K |
| 90671 | <1% | 952 | $128K | |
| 95720 | <1% | 1,081 | $125K | |
| 92060 | <1% | 2,347 | $122K | |
| 84484 | <1% | 45,084 | $118K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,285 | $117K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,484 | $117K |
| 84100 | <1% | 248,017 | $115K | |
| 93308 | <1% | 4,069 | $114K | |
| 00920 | <1% | 874 | $114K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 8,025 | $112K |
| 76775 | <1% | 6,941 | $109K | |
| 90461 | <1% | 5,516 | $108K | |
| 71250 | <1% | 5,705 | $108K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 7,996 | $105K |
| 70496 | <1% | 2,008 | $102K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,024 | $96K |
| 90670 | <1% | 2,406 | $96K | |
| 87040 | <1% | 32,416 | $93K | |
| 97802 | <1% | 1,588 | $90K | |
| 85390 | <1% | 6,722 | $86K | |
| 54150 | <1% | 1,456 | $86K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,508 | $84K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 998 | $84K |
| 0099U | <1% | 1,272 | $82K | |
| 86922 | <1% | 4,143 | $81K | |
| 31231 | <1% | 982 | $78K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,880 | $76K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 10,232 | $76K |
| 99221 | <1% | 1,145 | $73K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,736 | $72K |
| 70498 | <1% | 2,597 | $65K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,367 | $63K |
| 87497 | <1% | 6,798 | $62K | |
| 93970 | <1% | 3,827 | $60K | |
| T1024 | Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter | <1% | 544 | $60K |
| 93325 | <1% | 22,298 | $60K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,479 | $58K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12,413 | $58K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 22,530 | $57K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,630 | $56K |
| 99253 | <1% | 886 | $56K | |
| 85384 | <1% | 32,881 | $55K | |
| 81025 | <1% | 23,723 | $55K | |
| 81001 | <1% | 73,860 | $55K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 562 | $55K |
| 84145 | <1% | 21,595 | $54K | |
| 70491 | <1% | 1,704 | $53K | |
| 93976 | <1% | 2,498 | $52K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,215 | $52K |
| 80197 | <1% | 20,846 | $52K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 32,104 | $52K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,071 | $52K |
| 80202 | <1% | 18,256 | $52K | |
| 85610 | <1% | 83,741 | $51K | |
| 76818 | <1% | 794 | $51K | |
| 0097U | <1% | 493 | $51K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,160 | $51K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,925 | $47K |
| 95951 | <1% | 498 | $44K | |
| 82784 | <1% | 8,554 | $43K | |
| 86833 | <1% | 942 | $43K | |
| 82728 | <1% | 21,113 | $43K | |
| 78816 | <1% | 949 | $42K | |
| 85520 | <1% | 21,539 | $42K | |
| 94060 | <1% | 3,980 | $42K | |
| 82248 | <1% | 92,645 | $42K | |
| 85730 | <1% | 41,263 | $41K | |
| 73564 | <1% | 7,946 | $40K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 22,238 | $40K |
| 01961 | <1% | 188 | $39K | |
| 82375 | <1% | 28,957 | $39K | |
| 31575 | <1% | 907 | $37K | |
| 87186 | <1% | 16,619 | $37K | |
| 88108 | <1% | 2,587 | $36K | |
| 87070 | <1% | 17,099 | $36K | |
| 83970 | <1% | 4,804 | $36K | |
| 93321 | <1% | 13,923 | $36K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 56 | $34K |
| 84132 | <1% | 41,025 | $34K | |
| 85576 | <1% | 11,474 | $33K | |
| 93320 | <1% | 5,297 | $33K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 901 | $33K |
| 99464 | <1% | 722 | $33K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,496 | $33K |
| 87077 | <1% | 24,969 | $32K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,179 | $32K |
| 73610 | <1% | 7,473 | $32K | |
| 73110 | <1% | 6,909 | $32K | |
| 87486 | <1% | 3,306 | $32K | |
| 87799 | <1% | 3,537 | $31K | |
| 87507 | <1% | 1,786 | $30K | |
| 95819 | <1% | 102 | $30K | |
| 86803 | <1% | 10,225 | $30K | |
| 73130 | <1% | 6,992 | $29K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,714 | $29K |
| 84702 | <1% | 11,391 | $29K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,115 | $28K |
| 86900 | <1% | 68,851 | $28K | |
| 96112 | <1% | 218 | $28K | |
| 73630 | <1% | 8,164 | $28K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,223 | $27K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,953 | $27K |
| 82607 | <1% | 12,136 | $27K | |
| 85045 | <1% | 17,412 | $27K | |
| 73030 | <1% | 7,189 | $27K | |
| 80076 | <1% | 19,186 | $27K | |
| 01922 | <1% | 317 | $26K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 2,046 | $25K |
| 83690 | <1% | 37,087 | $25K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 232 | $25K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 968 | $24K |
| 99245 | <1% | 234 | $24K | |
| 76642 | <1% | 1,271 | $24K | |
| 76813 | <1% | 364 | $23K | |
| 84134 | <1% | 9,383 | $23K | |
| 80061 | Lipid panel | <1% | 14,152 | $23K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,335 | $22K |
| 87081 | <1% | 17,425 | $22K | |
| 82140 | <1% | 9,126 | $21K | |
| 92134 | <1% | 2,419 | $21K | |
| 93971 | <1% | 2,154 | $21K | |
| 84295 | <1% | 33,410 | $21K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,211 | $21K |
| 93295 | <1% | 1,181 | $21K | |
| 73560 | <1% | 6,203 | $20K | |
| 92552 | <1% | 849 | $20K | |
| 86901 | <1% | 69,470 | $19K | |
| 80074 | <1% | 3,154 | $19K | |
| 95117 | <1% | 2,036 | $19K | |
| 78264 | <1% | 1,008 | $18K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 366 | $18K |
| 88342 | <1% | 1,771 | $17K | |
| 70480 | <1% | 516 | $17K | |
| 81003 | <1% | 18,547 | $17K | |
| 80047 | <1% | 6,419 | $17K | |
| 82746 | <1% | 8,706 | $17K | |
| 86317 | <1% | 4,657 | $17K | |
| 73590 | <1% | 4,492 | $15K | |
| 82247 | <1% | 15,151 | $15K | |
| 72082 | <1% | 1,540 | $15K | |
| 70487 | <1% | 1,173 | $15K | |
| 93000 | <1% | 2,587 | $15K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,147 | $15K |
| 99460 | <1% | 319 | $15K | |
| 76506 | <1% | 714 | $15K | |
| 94010 | <1% | 2,892 | $15K | |
| 93227 | <1% | 699 | $14K | |
| 59515 | <1% | 12 | $14K | |
| 85014 | <1% | 28,700 | $14K | |
| 82533 | <1% | 4,715 | $14K | |
| 70486 | <1% | 635 | $14K | |
| 83050 | <1% | 29,017 | $14K | |
| 99255 | <1% | 109 | $14K | |
| 80069 | <1% | 10,589 | $14K | |
| 76820 | <1% | 1,289 | $14K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 194 | $13K |
| 86905 | <1% | 1,547 | $13K | |
| 82962 | <1% | 17,789 | $13K | |
| 83550 | <1% | 15,067 | $13K | |
| 87340 | <1% | 11,453 | $13K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 195 | $13K |
| 85347 | <1% | 12,291 | $12K | |
| 99219 | <1% | 108 | $12K | |
| 17311 | <1% | 79 | $12K | |
| 92083 | <1% | 765 | $12K | |
| 85652 | <1% | 22,500 | $12K | |
| 70543 | <1% | 272 | $12K | |
| 86880 | <1% | 7,923 | $12K | |
| 83540 | <1% | 15,705 | $12K | |
| 85379 | <1% | 9,811 | $12K | |
| 83615 | <1% | 19,295 | $12K | |
| 73090 | <1% | 2,863 | $11K | |
| 82570 | <1% | 14,135 | $11K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 460 | $11K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 12 | $11K |
| 84439 | <1% | 12,868 | $11K | |
| 99254 | <1% | 97 | $11K | |
| 82077 | <1% | 5,265 | $11K | |
| 87150 | <1% | 727 | $11K | |
| 93272 | <1% | 622 | $10K | |
| 87529 | <1% | 1,242 | $10K | |
| 74240 | <1% | 489 | $10K | |
| 94726 | <1% | 1,197 | $10K | |
| 41010 | <1% | 159 | $10K | |
| 82550 | <1% | 11,930 | $10K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 262 | $10K |
| 90633 | <1% | 344 | $10K | |
| 73502 | <1% | 2,416 | $10K | |
| 0151U | <1% | 192 | $10K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,061 | $10K |
| 29075 | <1% | 234 | $10K | |
| 86762 | <1% | 4,343 | $9K | |
| 83020 | <1% | 3,842 | $9K | |
| 87102 | <1% | 5,422 | $9K | |
| 92201 | <1% | 1,279 | $9K | |
| 87116 | <1% | 3,692 | $9K | |
| 86160 | <1% | 2,465 | $9K | |
| 73070 | <1% | 2,053 | $9K | |
| 99152 | <1% | 2,481 | $9K | |
| 85018 | <1% | 10,208 | $9K | |
| 88304 | <1% | 667 | $9K | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 271 | $9K |
| 80320 | <1% | 3,200 | $9K | |
| 87075 | <1% | 3,009 | $8K | |
| 73140 | <1% | 2,265 | $8K | |
| 82977 | <1% | 10,873 | $8K | |
| 86870 | <1% | 3,057 | $8K | |
| J0475 | Injection, baclofen, 10 mg | <1% | 16 | $8K |
| 54300 | <1% | 15 | $8K | |
| 93296 | <1% | 2,419 | $8K | |
| 73100 | <1% | 1,506 | $7K | |
| 82565 | <1% | 11,614 | $7K | |
| 91200 | <1% | 365 | $7K | |
| 73552 | <1% | 1,833 | $7K | |
| 99292 | <1% | 164 | $7K | |
| 17110 | <1% | 192 | $7K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 170 | $7K |
| 87483 | <1% | 177 | $7K | |
| 87581 | <1% | 3,305 | $7K | |
| 99051 | <1% | 1,927 | $7K | |
| 87205 | <1% | 16,394 | $7K | |
| 93798 | <1% | 1,017 | $7K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,679 | $7K |
| 80051 | <1% | 5,037 | $7K | |
| 95816 | <1% | 96 | $7K | |
| 20611 | <1% | 211 | $6K | |
| 72170 | <1% | 1,790 | $6K | |
| 20610 | <1% | 262 | $6K | |
| 88142 | <1% | 2,218 | $6K | |
| 82105 | <1% | 1,840 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,908 | $6K |
| 82136 | <1% | 1,106 | $6K | |
| 95718 | <1% | 62 | $6K | |
| 11102 | <1% | 151 | $6K | |
| 88312 | <1% | 469 | $6K | |
| 00731 | <1% | 71 | $6K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 820 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,506 | $6K |
| 87154 | <1% | 151 | $6K | |
| 87103 | <1% | 2,029 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,910 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 114 | $5K |
| 62322 | <1% | 103 | $5K | |
| 83010 | <1% | 3,479 | $5K | |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 39 | $5K |
| 0002A | <1% | 134 | $5K | |
| 86359 | <1% | 3,552 | $5K | |
| 0001A | <1% | 185 | $5K | |
| 94729 | <1% | 2,050 | $5K | |
| 83930 | <1% | 5,691 | $5K | |
| 0072A | <1% | 200 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 75 | $5K |
| 86355 | <1% | 2,512 | $5K | |
| 0353U | <1% | 127 | $5K | |
| 82378 | <1% | 1,668 | $5K | |
| 77066 | Tomosynthesis, mammo | <1% | 173 | $5K |
| 69210 | <1% | 393 | $4K | |
| 84156 | <1% | 9,421 | $4K | |
| 99188 | <1% | 678 | $4K | |
| 84550 | <1% | 8,869 | $4K | |
| 00126 | <1% | 63 | $4K | |
| 84703 | <1% | 5,101 | $4K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 396 | $4K |
| 82150 | <1% | 5,017 | $4K | |
| 87541 | <1% | 953 | $4K | |
| 96113 | <1% | 61 | $4K | |
| 58340 | <1% | 37 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,095 | $4K |
| 75574 | <1% | 88 | $4K | |
| 90870 | <1% | 114 | $4K | |
| 82310 | <1% | 5,275 | $4K | |
| 86360 | <1% | 1,824 | $4K | |
| 88189 | <1% | 78 | $4K | |
| 77080 | <1% | 698 | $4K | |
| 80195 | <1% | 1,821 | $4K | |
| T1027 | Family training and counseling for child development, per 15 minutes | <1% | 74 | $4K |
| 87640 | <1% | 940 | $4K | |
| 86920 | <1% | 1,103 | $4K | |
| 74183 | <1% | 66 | $4K | |
| 93923 | <1% | 111 | $4K | |
| 84300 | <1% | 6,111 | $3K | |
| 90961 | <1% | 148 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,490 | $3K |
| 83935 | <1% | 3,198 | $3K | |
| 87106 | <1% | 2,122 | $3K | |
| 78306 | <1% | 222 | $3K | |
| 87641 | <1% | 657 | $3K | |
| 80164 | <1% | 1,314 | $3K | |
| 77072 | <1% | 602 | $3K | |
| 87632 | <1% | 313 | $3K | |
| 74230 | <1% | 251 | $3K | |
| 84520 | <1% | 6,908 | $3K | |
| 87184 | <1% | 3,600 | $3K | |
| 95115 | <1% | 346 | $3K | |
| 92015 | Determination of refractive state | <1% | 291 | $3K |
| 86704 | <1% | 2,060 | $3K | |
| 99441 | <1% | 90 | $3K | |
| 54163 | <1% | 12 | $3K | |
| 99220 | <1% | 31 | $3K | |
| 84480 | <1% | 1,948 | $3K | |
| 93294 | <1% | 283 | $3K | |
| 72131 | <1% | 135 | $3K | |
| 0071A | <1% | 132 | $3K | |
| 0012A | <1% | 378 | $3K | |
| 82945 | <1% | 3,918 | $3K | |
| 87400 | <1% | 1,403 | $3K | |
| 76937 | <1% | 518 | $3K | |
| 93356 | <1% | 592 | $3K | |
| 00811 | <1% | 58 | $3K | |
| 82010 | <1% | 3,598 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 87 | $3K |
| 83001 | <1% | 912 | $3K | |
| 73521 | <1% | 360 | $3K | |
| 99383 | <1% | 27 | $2K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 154 | $2K |
| 84153 | <1% | 831 | $2K | |
| 84146 | <1% | 599 | $2K | |
| 86431 | <1% | 1,227 | $2K | |
| 90678 | <1% | 16 | $2K | |
| 73600 | <1% | 459 | $2K | |
| 99201 | <1% | 45 | $2K | |
| 87210 | <1% | 3,515 | $2K | |
| 86356 | <1% | 224 | $2K | |
| 90672 | <1% | 190 | $2K | |
| 84478 | <1% | 2,405 | $2K | |
| 0298T | <1% | 61 | $2K | |
| 86376 | <1% | 948 | $2K | |
| 77014 | <1% | 73 | $2K | |
| 84403 | <1% | 357 | $2K | |
| 88173 | <1% | 31 | $2K | |
| 92250 | <1% | 235 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,027 | $2K |
| 84157 | <1% | 4,163 | $2K | |
| 82270 | <1% | 1,778 | $2K | |
| 80305 | <1% | 310 | $2K | |
| 87206 | <1% | 3,656 | $2K | |
| 72100 | <1% | 349 | $2K | |
| 99358 | Prolong nursin fac eval 15m | <1% | 42 | $2K |
| 85613 | <1% | 1,031 | $2K | |
| 99443 | <1% | 95 | $2K | |
| 76825 | <1% | 28 | $2K | |
| 85246 | <1% | 225 | $2K | |
| 80170 | <1% | 499 | $2K | |
| 83002 | <1% | 565 | $2K | |
| 88311 | <1% | 798 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 17 | $2K |
| 76536 | <1% | 88 | $1K | |
| 93886 | <1% | 52 | $1K | |
| 95885 | <1% | 30 | $1K | |
| 51798 | <1% | 1,041 | $1K | |
| 80179 | <1% | 629 | $1K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 358 | $1K |
| 83520 | <1% | 411 | $1K | |
| 42830 | <1% | 13 | $1K | |
| 95886 | <1% | 66 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 90 | $1K |
| 99459 | <1% | 127 | $1K | |
| 73620 | <1% | 303 | $1K | |
| 86301 | <1% | 422 | $1K | |
| 86357 | <1% | 1,235 | $1K | |
| 0011A | <1% | 338 | $1K | |
| 90715 | <1% | 154 | $1K | |
| 85240 | <1% | 456 | $1K | |
| 99252 | <1% | 30 | $1K | |
| 84165 | <1% | 1,298 | $1K | |
| 31237 | <1% | 43 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 14 | $1K |
| 83051 | <1% | 583 | $1K | |
| 92202 | <1% | 219 | $1K | |
| 73700 | <1% | 47 | $1K | |
| 83883 | <1% | 321 | $1K | |
| 01996 | <1% | 26 | $925.84 | |
| 43762 | <1% | 26 | $917.78 | |
| 86592 | <1% | 1,559 | $902.61 | |
| 82950 | <1% | 1,233 | $839.48 | |
| 87420 | <1% | 292 | $829.08 | |
| 90723 | <1% | 1,090 | $820.20 | |
| 84540 | <1% | 1,429 | $819.98 | |
| 88302 | <1% | 51 | $814.51 | |
| 64615 | <1% | 19 | $799.96 | |
| 92226 | <1% | 233 | $758.92 | |
| 76831 | <1% | 24 | $753.10 | |
| 80184 | <1% | 268 | $733.77 | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 19 | $732.00 |
| 99462 | <1% | 15 | $726.66 | |
| 99242 | <1% | 18 | $718.53 | |
| 90647 | <1% | 1,181 | $710.70 | |
| 85732 | <1% | 975 | $707.07 | |
| 74019 | <1% | 152 | $700.38 | |
| 86769 | <1% | 206 | $699.38 | |
| 89051 | <1% | 665 | $667.80 | |
| 88341 | <1% | 75 | $659.19 | |
| 93975 | <1% | 14 | $642.59 | |
| 80165 | <1% | 523 | $638.14 | |
| 76801 | <1% | 13 | $632.52 | |
| 73080 | <1% | 106 | $631.16 | |
| 86828 | <1% | 93 | $624.00 | |
| 92133 | <1% | 102 | $617.28 | |
| 82390 | <1% | 535 | $604.96 | |
| 73120 | <1% | 155 | $595.62 | |
| H0049 | Alcohol and/or drug screening | <1% | 33 | $587.52 |
| 86706 | <1% | 457 | $545.82 | |
| 73562 | <1% | 47 | $535.05 | |
| 59430 | <1% | 17 | $523.75 | |
| 99318 | <1% | 40 | $522.31 | |
| 84311 | <1% | 546 | $515.11 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 17,073 | $490.81 |
| 87045 | <1% | 106 | $486.26 | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 37 | $485.10 |
| 81050 | <1% | 1,093 | $484.61 | |
| 93451 | <1% | 12 | $477.95 | |
| 95874 | <1% | 29 | $477.71 | |
| 99177 | <1% | 70 | $475.20 | |
| 74178 | <1% | 16 | $468.00 | |
| 83521 | <1% | 76 | $462.67 | |
| 62369 | <1% | 19 | $461.92 | |
| 77062 | <1% | 41 | $460.05 | |
| 95822 | <1% | 15 | $459.23 | |
| 82465 | <1% | 76 | $439.60 | |
| 84460 | <1% | 779 | $432.18 | |
| 88300 | <1% | 50 | $420.21 | |
| 82040 | <1% | 543 | $418.51 | |
| 86334 | <1% | 324 | $415.63 | |
| 77001 | <1% | 195 | $411.25 | |
| 11104 | <1% | 13 | $392.13 | |
| 87808 | <1% | 60 | $381.99 | |
| 80143 | <1% | 704 | $368.43 | |
| 99446 | <1% | 102 | $364.82 | |
| 70355 | <1% | 93 | $344.72 | |
| 93244 | <1% | 16 | $323.11 | |
| 95812 | <1% | 12 | $310.24 | |
| 72081 | <1% | 37 | $305.70 | |
| 70250 | <1% | 42 | $290.98 | |
| 84155 | <1% | 641 | $288.32 | |
| 85461 | <1% | 147 | $279.31 | |
| 84075 | <1% | 360 | $269.47 | |
| 84450 | <1% | 510 | $260.91 | |
| 88141 | <1% | 13 | $249.90 | |
| 83529 | <1% | 51 | $249.66 | |
| 86308 | <1% | 428 | $240.84 | |
| 76827 | <1% | 28 | $232.54 | |
| 90681 | <1% | 92 | $231.00 | |
| 76885 | <1% | 13 | $229.43 | |
| 85460 | <1% | 271 | $228.35 | |
| 99307 | <1% | 18 | $226.01 | |
| 86705 | <1% | 157 | $213.99 | |
| 77073 | <1% | 29 | $213.28 | |
| 90651 | <1% | 136 | $208.44 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 24 | $206.00 |
| 90474 | <1% | 28 | $202.30 | |
| 82610 | <1% | 71 | $202.20 | |
| 87807 | <1% | 49 | $201.51 | |
| 73060 | <1% | 48 | $169.65 | |
| 82103 | <1% | 132 | $167.33 | |
| 87449 | <1% | 20 | $164.68 | |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 20 | $161.93 |
| 87905 | <1% | 30 | $160.68 | |
| 87071 | <1% | 127 | $149.68 | |
| 82340 | <1% | 69 | $148.80 | |
| 88313 | <1% | 14 | $145.80 | |
| 84133 | <1% | 446 | $139.37 | |
| 77002 | <1% | 13 | $133.85 | |
| 82438 | <1% | 145 | $129.82 | |
| 76870 | <1% | 14 | $127.91 | |
| 64642 | <1% | 12 | $122.29 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 26 | $117.64 |
| 73522 | <1% | 18 | $116.80 | |
| 90710 | <1% | 12 | $113.29 | |
| 86860 | <1% | 30 | $110.67 | |
| 93016 | <1% | 12 | $104.84 | |
| 87107 | <1% | 162 | $103.23 | |
| 73020 | <1% | 34 | $99.92 | |
| 82436 | <1% | 303 | $92.50 | |
| 80186 | <1% | 47 | $86.72 | |
| 87899 | <1% | 41 | $85.83 | |
| 82948 | <1% | 374 | $76.81 | |
| 72040 | <1% | 14 | $75.46 | |
| 99354 | <1% | 39 | $71.86 | |
| 83525 | <1% | 84 | $66.12 | |
| 85300 | <1% | 50 | $65.39 | |
| 90620 | <1% | 56 | $59.97 | |
| 82374 | <1% | 83 | $55.68 | |
| 86403 | <1% | 48 | $54.63 | |
| 85306 | <1% | 13 | $53.06 | |
| 93297 | <1% | 78 | $51.84 | |
| 36416 | <1% | 14 | $48.00 | |
| 73501 | <1% | 15 | $46.78 | |
| 87046 | <1% | 107 | $46.12 | |
| 86885 | <1% | 26 | $39.86 | |
| 95251 | <1% | 39 | $38.85 | |
| 86022 | <1% | 14 | $33.45 | |
| 84166 | <1% | 75 | $30.94 | |
| 76377 | <1% | 30 | $30.37 | |
| 82553 | <1% | 84 | $28.88 | |
| 90696 | <1% | 12 | $21.00 | |
| 83986 | <1% | 19 | $19.33 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $13.14 |
| 87327 | <1% | 15 | $12.88 | |
| 86060 | <1% | 15 | $8.83 | |
| 81002 | <1% | 71 | $7.10 | |
| 91307 | <1% | 146 | $0.01 | |
| 90734 | 0% | 57 | $0.00 | |
| 91321 | 0% | 13 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 29 | $0.00 |
| 90677 | 0% | 26 | $0.00 | |
| 96161 | 0% | 28 | $0.00 | |
| 82043 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIBISKI, JEREMY (EXECUTIVE DIRECTOR OF FINANCE & ADM)
| Provider | Location | Paid |
|---|---|---|
| Florida Clinical Practice Association INC | Gainesville, FL | $3.13M |
| Florida Clinical Practice Association INC | Gainesville, FL | $132K |
| Florida Clinical Practice Association INC | Gainesville, FL | $28K |
| Florida Clinical Practice Association INC | Gainesville, FL | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.